why choose us

First received: November 7, 2022

Clinical Trial: Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes

Study Status: Active, not recruiting

Recruit Status: Active, not recruiting

Condition: Type 1 Diabetes
Diabetes Mellitus, Type 1

Study Type: Interventional


Official Title: Clinical Trial to Evaluate the Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes (CREATE-1)

Brief Summary: The brief purpose of this research study is to learn about the safety and efficacy of intra-arterial administration of CELZ-201 in patients with newly diagnosed Type 1 Diabetes Mellitus (T1D).

Read more